Skip to main content
MDLNMedline Inc.Sell5.8·$36.41-0.51%

Medline (MDLN) Q2 2026 earnings — TrendMatrix coverage

BEAT+55.8% vs estimateEPS $0.50 vs $0.32 estCurrent verdict Sell 5.8/10

Reported

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure

Event detail · Q2 2026

Key numbers

Reported EPS
$0.50
Estimate
$0.32
Surprise
+55.8%
Revenue (period 2026-06-27)
$7.68B
Score today
5.8/10

Revenue source: mixed.

Report record · Q2 2026

How the report landed

Medline (MDLN) beat the $0.32 estimate with diluted EPS of $0.50 — a large 55.8% upside surprise.

Current read · as of 2026-09-04

Where TrendMatrix's rating stands now

TrendMatrix currently rates MDLN Sell at 5.8/10; no pre/post engine snapshot brackets this report.

3 of the last 3 quarters beat the estimate; this quarter's +55.8% surprise compares with a +32.7% four-quarter average. Next scheduled report: 2026-11-04.

What supports the rating

  • Sector modifier (Healthcare): +0.5
  • Strong earnings beat streak (3/4)

What argues against it

  • Concentration risk — Customer: Vizient Supply, HealthTrust Purchasing Group, and Premier Healthcare Alliance (GPOs) (69.0%)
  • Thin upside margin: 9.7%
  • V7 low-quality RISK_OFF penalty: -0.5 (Q=4.2)

This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.

Current engine read

The levels TrendMatrix's engine tracks

Current price
$36.41
Price target
$40.14
Stop
$34.07
Upside to target
+10.2%
Reward-to-risk
0.9:1

The stock trades at 45.7× trailing but 23.1× forward earnings — consensus estimates already build in a substantial earnings recovery.

Model outputs from TrendMatrix’s engine as of 2026-09-04 — shown for context, not personalized investment advice.

Healthcare context

MDLN at TrendMatrix's latest read

Healthcare earnings trade on pipeline and payer dynamics as much as the quarter itself; a beat or miss is weighed against trial and reimbursement news.

Industry
Medical Instruments & Supplies
Market cap
$49.23B
P/E (fwd)
23.1
P/E (ttm)
45.7
52-week range
$32.48$50.88
Off 52-week high
28.4%
RSI (14)
54
Volume vs avg
0.83×
Score today
5.8/10

Earnings figures are sourced from TrendMatrix’s pipeline (EPS: existing earnings extraction; revenue: SEC XBRL company facts where available, yfinance-provisional otherwise). Not a buy/sell rating, a price target, or investment advice — see the current verdict on the stock’s main page for TrendMatrix’s live read.

Home Stocks MDLN Earnings Q2 2026 earnings